These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29018797)

  • 1. microRNAs Make the Call in Cancer Personalized Medicine.
    Detassis S; Grasso M; Del Vescovo V; Denti MA
    Front Cell Dev Biol; 2017; 5():86. PubMed ID: 29018797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Improve Cancer Treatment Outcomes Through Personalized Medicine.
    Hatam S
    Microrna; 2023; 12(2):92-98. PubMed ID: 36733205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer and microRNAs: therapeutic impact.
    Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
    Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-221: biogenesis, function and signatures in human cancers.
    Abak A; Amini S; Sakhinia E; Abhari A
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in Cancer: the 22nd Hiroshima Cancer Seminar/the 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima.
    Tahara H; Kay MA; Yasui W; Tahara E
    Jpn J Clin Oncol; 2013 May; 43(5):579-82. PubMed ID: 23487440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of microRNA dynamics on cancer hallmarks: An oral cancer scenario.
    Manasa VG; Kannan S
    Tumour Biol; 2017 Mar; 39(3):1010428317695920. PubMed ID: 28347239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells.
    Wm Nor WMFSB; Chung I; Said NABM
    Oncol Res; 2021 Mar; 28(6):615-629. PubMed ID: 33109304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis.
    Chen ZY; Chen X; Wang ZX
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27752997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as Therapeutic Agents: The Future of the Battle Against Cancer.
    Biswas S
    Curr Top Med Chem; 2018; 18(30):2544-2554. PubMed ID: 30457051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review).
    Palma Flores C; García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Astudillo de la Vega H; Marchat LA; Salinas Vera YM; López-Camarillo C
    Int J Oncol; 2017 May; 50(5):1461-1476. PubMed ID: 28393213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico interaction of HOX cluster-embedded microRNAs and long non-coding RNAs in oral cancer.
    Padam KSR; Basavarajappa DS; Shenoy US; Chakrabarty S; Kabekkodu SP; Hunter KD; Radhakrishnan R
    J Oral Pathol Med; 2022 Jan; 51(1):18-29. PubMed ID: 34358375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1236: Key controller of tumor development and progression: Focus on the biological functions and molecular mechanisms.
    Babaei Z; Keyvanloo Shahrestanaki M; Aghaei M
    Pathol Res Pract; 2023 Aug; 248():154671. PubMed ID: 37418995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
    Cao Z; Qiu J; Yang G; Liu Y; Luo W; You L; Zheng L; Zhang T
    Cancer Biol Med; 2020 Aug; 17(3):569-582. PubMed ID: 32944391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression
    Wang XD; Lu J; Lin YS; Gao C; Qi F
    World J Gastroenterol; 2019 Apr; 25(14):1697-1714. PubMed ID: 31011255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.